SodaTide is a once-daily synbiotic capsule combining 211 mg chicory root inulin, 100 mg potato resistant starch and three probiotic strains. Label facts, pricing and availability.
LAKELAND, FL — August 20, 2026 — SodaTide today announced the availability of SodaTide, a once-daily synbiotic capsule dietary supplement made in the USA with globally sourced ingredients and backed by a 60-day money-back guarantee. The product is available through the official website at mysodatide.com.
SodaTide is a once-daily vegetarian capsule. Its active ingredient list consists of two prebiotic fibers and a three-strain probiotic blend: Chicory Root Inulin, Potato Resistant Starch, Bifidobacterium infantis, Clostridium butyricum and Akkermansia muciniphila. Each bottle provides a 30-day supply at the recommended one-capsule daily serving. Both prebiotic ingredients are identified individually on the Supplement Facts panel with their milligram amounts and their botanical sources.
SodaTide Official website at mysodatide.com (affiliate link — see disclosure below)
Product Overview
SodaTide is a capsule taken once a day with an eight-ounce glass of water. One bottle holds 30 capsules, a one-month supply. The label directs buyers to refrigerate the bottle for optimal quality and to keep it away from heat, light and humidity.
The formula is built as a synbiotic, meaning it supplies prebiotic substrates and live probiotic organisms in the same dose rather than separately. The stated design intent is to deliver both the organisms and the fermentable fiber those organisms use as substrate.
Per capsule, the Supplement Facts panel discloses: Chicory Root Inulin (Cichorium intybus, root) 211 mg, Potato Resistant Starch (tuber) 100 mg, and a Probiotic Blend of 36 mg containing Bifidobacterium infantis, Clostridium butyricum and Akkermansia muciniphila. Daily Value is not established for any of the three entries. Other ingredients are listed as hypromellose (vegetarian capsule), microcrystalline cellulose, magnesium stearate and silica. The two prebiotic amounts total 311 mg per capsule.
Buyers comparing probiotic products on colony-forming units should note what this panel does and does not disclose. The probiotic blend is printed as a combined 36 mg weight. Per-strain milligram amounts are not broken out, and no CFU count is stated for the blend or for any individual strain. Several competing products in this category print a CFU figure; SodaTide’s panel does not.
The company states that its ingredients were selected on the basis of their records in published nutritional science literature. The company does not claim that the product replicates the outcomes of any independently conducted study, and the scientific references cited in this press release were conducted under research conditions unaffiliated with SodaTide.
“The two prebiotic ingredients are printed individually with their amounts and their botanical sources rather than folded into a proprietary blend, because a buyer is entitled to see exactly what is in the capsule and to weigh it against whatever information they choose to consult. Each ingredient has a record in the published nutritional science literature and was selected on that basis. SodaTide does not claim to replicate the outcomes of the studies published on these ingredients, which were conducted independently and under conditions unaffiliated with the company. This is a general wellness product for adults, and it is not a substitute for the eating and activity patterns that determine long-term digestive and metabolic health.”
— Sarah Andrews, SodaTide Media Relations
SodaTide Ingredients: What Is in the Formula
What follows is background on each SodaTide ingredient and the published research that exists on it. That research was carried out by independent scientists studying these compounds and organisms on their own, not studying SodaTide. It does not show that this product produces the same results, and SodaTide makes no such claim.
Chicory Root Inulin — 211 mg. A fructan fiber extracted from chicory root. It resists digestion in the small intestine and is fermented by bacteria in the colon, which is what makes it a prebiotic. In 2015 the European Food Safety Authority published a scientific opinion concluding that a cause-and-effect relationship had been established between the consumption of native chicory inulin and the maintenance of normal defecation by increasing stool frequency (EFSA Panel on Dietetic Products, Nutrition and Allergies, EFSA Journal, 2015;13(1):3951, doi:10.2903/j.efsa.2015.3951). That conclusion was substantiated at an intake of 12 grams of native chicory inulin per day, an amount substantially larger than the 211 mg present in one SodaTide capsule. This opinion was issued independently and was not affiliated with SodaTide.
Potato Resistant Starch — 100 mg. Starch from potato tuber in a form, classified as resistant starch type 2, that passes through the small intestine largely undigested and is fermented in the large intestine into short-chain fatty acids including butyrate. A controlled study published in the American Journal of Clinical Nutrition (Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN, 2005, “Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism,” PMID 16155268) examined resistant starch supplementation in healthy adult subjects using 30 grams per day over four weeks. The amount used in that study is roughly three hundred times the amount in one SodaTide capsule. This study was conducted independently and was not affiliated with SodaTide.
Akkermansia muciniphila. A bacterium that lives in the mucus layer of the human gut and is often described in the trade press as a next-generation probiotic. A proof-of-concept exploratory study published in Nature Medicine (Depommier C, Everard A, Druart C, et al., 2019, “Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study,” doi:10.1038/s41591-019-0495-2) followed 32 volunteers over three months. The authors described their own work as exploratory and called for larger confirmatory trials. Human evidence on this organism remains limited relative to more established probiotic genera. These studies were conducted independently and were not affiliated with SodaTide.
Bifidobacterium infantis. A Bifidobacterium species commonly present in the human gastrointestinal tract, particularly in infancy, and studied for its capacity to ferment complex carbohydrates. A randomized controlled trial published in the American Journal of Gastroenterology (Whorwell PJ, Altringer L, Morel J, et al., 2006, “Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome,” Am J Gastroenterol. 2006;101(7):1581–1590, PMID 16863564) evaluated one specific strain at one specific dose. Probiotic findings are strain-specific: results reported for strain 35624 do not transfer to a different B. infantis strain, and SodaTide’s panel does not identify which strain it contains. These studies were conducted independently and were not affiliated with SodaTide.
Clostridium butyricum. A butyrate-producing organism that has been used in commercial probiotic preparations in Japan for several decades, most familiarly as strain MIYAIRI 588. A clinical evaluation published in Frontiers in Medicine (2025, “Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11,” doi:10.3389/fmed.2025.1604319) examined this organism in adult subjects. As with the other strains in this formula, the panel does not identify which C. butyricum strain is used. These studies were conducted independently and were not affiliated with SodaTide.
The full ingredient composition is disclosed on the product label, available for review at mysodatide.com.
Market Context
The following market data is provided as independent industry context for the dietary supplement category in which this product operates. The figures cited are sourced from third-party market research firms and federal agencies and are not claims made by SodaTide regarding its own commercial performance or product outcomes.
The global synbiotic product market was valued at approximately $1.1 billion in 2025 and is projected to reach $2.0 billion by 2033, at a compound annual growth rate of 7.6 percent, according to Grand View Research (Synbiotic Product Market Size, Share & Trends Analysis Report, Grand View Research; grandviewresearch.com).
The broader probiotic dietary supplements market was valued by the same firm at approximately $10.5 billion in 2025 and is projected to reach $17.5 billion by 2033, at a compound annual growth rate of 6.5 percent (Probiotic Dietary Supplements Market Size, Share & Trends Analysis Report, Grand View Research; grandviewresearch.com). The firm attributes much of that growth to consumer interest in the gut microbiome and to demand for formulations that disclose their contents on the label.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, digestive conditions affect tens of millions of adults in the United States, and digestive health is among the most commonly cited reasons adults report using dietary supplements.
The National Center for Complementary and Integrative Health states that the health effects of probiotics are specific to the strain and the dose studied, that a benefit demonstrated for one strain cannot be assumed for another, and that the evidence supporting many marketed uses of probiotics remains limited or inconclusive. The European Food Safety Authority has to date not authorised any health claim for a probiotic organism in the European Union. SodaTide is offered consistently with that guidance — as an optional addition to established eating and activity patterns, not as a replacement for them, and not as a treatment for any medical condition.
SodaTide Price, Packages, and Money-Back Guarantee
SodaTide is available through the official website at mysodatide.com. The product is offered in three supply configurations: a two-bottle package providing a 60-day supply at $79 per bottle, a three-bottle package providing a 90-day supply at $69 per bottle with complimentary domestic shipping included, and a six-bottle package providing a 180-day supply at $49 per bottle with complimentary domestic shipping included. Shipping on the two-bottle package is calculated at checkout at $9.99. No single-bottle configuration is offered.
All purchases are one-time transactions with no automatic subscription enrollment. Orders carry a 60-day money-back guarantee measured from the date of purchase. The 60-day period is fixed regardless of package size. Refund requests are initiated through customer support at contact@customercs.com or +1 (507) 448-8190.
Current package pricing, shipping terms, and guarantee wording can be reviewed on the SodaTide product page. Pricing and promotional terms are controlled by the seller and may change without notice; the checkout total is the operative figure.
Is SodaTide Legit? Manufacturing, Sourcing, and Look-Alike Sellers
The company states that SodaTide is made in the USA with globally sourced ingredients. The capsule shell is hypromellose-based and contains no gelatin, and no animal-derived ingredient appears on the panel. Both prebiotic actives are identified individually with their amounts and their botanical sources. The probiotic component is disclosed as a combined blend weight without per-strain amounts or CFU counts, which is a common labeling practice in this category and which buyers comparing products should account for directly.
Each bottle is supplied with a safety seal. The label instructs consumers not to use the product if the seal is damaged or missing.
SodaTide is sold through mysodatide.com, and the money-back guarantee applies to purchases made through that channel. Purchases through general third-party marketplaces are not covered by the company’s guarantee or its customer support process. Buyers should be aware that several similarly spelled web addresses present themselves as official SodaTide sites, and that product descriptions differ between some of them. Confirm the seller of record before ordering, and check the Supplement Facts panel on the bottle received against the amounts published above.
SodaTide Dosage, Storage, and Side Effect Considerations
SodaTide is intended for adult use as a daily dietary supplement. The recommended serving is one capsule daily taken with an 8 oz. glass of water. The formula contains no caffeine and no stimulant ingredient, so time of day is not constrained by stimulant content.
The label directs users to refrigerate the bottle for optimal quality and to store it away from heat, light and humidity. Live microorganisms are sensitive to temperature and moisture, and storage conditions affect how many remain viable through the stated shelf life.
Adults who are new to fermentable fiber commonly report transient gas, bloating or changes in stool consistency when beginning a prebiotic, and these effects typically diminish with continued use. The product label states that SodaTide is not for use by children under the age of 18 or by pregnant or nursing mothers, directs users not to exceed the recommended dose, and advises that individuals with a known medical condition consult a physician before using this or any dietary supplement. Keep out of the reach of children.
Live-microbial supplements are not appropriate for everyone. The Centers for Disease Control and Prevention has published a report of Clostridium butyricum bacteremia associated with probiotic use in Japan (Emerging Infectious Diseases, 2024;30(4)), and the medical literature more broadly documents rare cases of probiotic-associated infection in people who are severely immunocompromised, critically ill, or have central venous catheters. These outcomes are rare relative to category exposure. Adults in those groups, and adults taking prescription medication or scheduled for a medical procedure, should consult a qualified healthcare provider before use. Individual responses may vary.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The scientific citations included in this press release describe independent research conducted on individual ingredients and organisms under conditions unaffiliated with SodaTide. They do not constitute clinical evidence that this product produces equivalent outcomes to those described in the cited studies, and no such equivalence is claimed by SodaTide. No published clinical trial has evaluated the complete SodaTide formulation as a finished product. The amounts used in the cited studies differ substantially from the amounts present in one capsule. This product is a dietary supplement and is not a substitute for medical advice, diagnosis, or treatment for any medical condition. Consult a qualified healthcare professional before use. Individual results may vary.
Affiliate Disclosure: This press release contains links to a retail partner website through which the distributor may receive compensation if a purchase is made following a referral. This disclosure is made in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). The existence of this affiliate relationship does not influence the factual content of this press release.
About SodaTide
SodaTide is a dietary supplement brand offering a once-daily synbiotic capsule made in the USA with globally sourced ingredients, containing Chicory Root Inulin and Potato Resistant Starch alongside a three-strain probiotic blend of Bifidobacterium infantis, Clostridium butyricum and Akkermansia muciniphila, with both prebiotic amounts individually disclosed on the Supplement Facts panel. 30 capsules per bottle. The product is available through the official website. All purchases are subject to a 60-day money-back guarantee. For more information, visit mysodatide.com.
Media Contact
Sarah Andrews
SodaTide Media Relations
contact@customercs.com
+1 (507) 448-8190
Distributed by Instituto Experience, Lakeland, FL 33804, USA
References
• EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the substantiation of a health claim related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency. EFSA Journal. 2015;13(1):3951. doi:10.2903/j.efsa.2015.3951
• Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr. 2005;82(3):559–567. PMID 16155268
• Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096–1103. doi:10.1038/s41591-019-0495-2
• Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581–1590. PMID 16863564
• Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11. Front Med. 2025. doi:10.3389/fmed.2025.1604319
• Centers for Disease Control and Prevention. Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan. Emerg Infect Dis. 2024;30(4)
• Grand View Research. Synbiotic Product Market Size, Share & Trends Analysis Report.
• Grand View Research. Probiotic Dietary Supplements Market Size, Share & Trends Analysis Report.
• National Center for Complementary and Integrative Health. Probiotics: What You Need To Know.
• National Institute of Diabetes and Digestive and Kidney Diseases. Digestive Diseases Statistics for the United States.
For more press release distribution and guest post services, visit TS Newswire.
